Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm: interim guidance, 7 May 2021

11 May 2021
 | Publication
Interim recommendations for use of the inactivated COVID-19 vaccine BIBP developed by China National Biotec Group (‎CNBG)‎, Sinopharm: interim guidance, 7 May 2021
Download (225.2 kB)
WHO Team
Joint Infectious Diseases Unit (JID), WHO Health Emergencies Programme (WHE)
Editors
World Health Organization. Regional Office for Europe
Reference numbers
WHO Reference Number: WHO/2019-nCoV/vaccines/SAGE_recommendation/BIBP/2021.1
Copyright